Virbac SA
PAR:VIRP

Watchlist Manager

Virbac SA

PAR:VIRP

Watchlist

Dividends

Price: 310 EUR -0.32%

Market Cap: 2.6B EUR

Have any thoughts about
Virbac SA?

Write Note

Write Note Create Alert Ask AI

Add Note Why Create Notes?

Capture your thoughts

Note Buy Sell Hold Pass

US	Johnson & Johnson NYSE:JNJ	Pharmaceuticals
US	Berkshire Hathaway Inc NYSE:BRK.A	Financial Services
US	Bank of America Corp NYSE:BAC	Banking
US	Mastercard Inc NYSE:MA	Technology
US	UnitedHealth Group Inc NYSE:UNH	Health Care
US	Exxon Mobil Corp NYSE:XOM	Energy
US	Pfizer Inc NYSE:PFE	Pharmaceuticals
US	Palantir Technologies Inc NYSE:PLTR	Technology
US	Nike Inc NYSE:NKE	Textiles, Apparel & Luxury Goods
US	Visa Inc NYSE:V	Technology
CN	Alibaba Group Holding Ltd NYSE:BABA	Retail
US	3M Co NYSE:MMM	Industrial Conglomerates
US	JPMorgan Chase & Co NYSE:JPM	Banking
US	Coca-Cola Co NYSE:KO	Beverages
US	Walmart Inc NYSE:WMT	Retail
US	Verizon Communications Inc NYSE:VZ	Telecommunication

Add Price Alert

Price Target:

Last Price: 310 EUR

We'll email you a reminder when the closing price reaches USD.

If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Peter Lynch

Track and Analyze Performance

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.

Continuous Learning and Adaptation

Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.

Boost Decision Confidence

With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.

Why create notes?

Back

Delete Note

Do you really want to delete this note?
This action cannot be undone.

Remove price alert for reaching

Delete

Cancel

VIRP Alert

Virbac SA

310

-1 (-0.32%)

52 Week Range	309.5 400
Price Target

We'll email you a reminder when the closing price reaches EUR.

Save Alert

Choose the stock you wish to monitor with a price alert.

	Johnson & Johnson NYSE:JNJ	US
	Berkshire Hathaway Inc NYSE:BRK.A	US
	Bank of America Corp NYSE:BAC	US
	Mastercard Inc NYSE:MA	US
	UnitedHealth Group Inc NYSE:UNH	US
	Exxon Mobil Corp NYSE:XOM	US
	Pfizer Inc NYSE:PFE	US
	Palantir Technologies Inc NYSE:PLTR	US
	Nike Inc NYSE:NKE	US
	Visa Inc NYSE:V	US
	Alibaba Group Holding Ltd NYSE:BABA	CN
	3M Co NYSE:MMM	US
	JPMorgan Chase & Co NYSE:JPM	US
	Coca-Cola Co NYSE:KO	US
	Walmart Inc NYSE:WMT	US
	Verizon Communications Inc NYSE:VZ	US

Delete Alert

This alert will be permanently deleted.

Remove note

Delete

Cancel

Ask me anything about

Virbac SA

What unique competitive advantages
does Virbac SA hold over its rivals?

What risks and challenges
does Virbac SA face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Provide an overview of the primary business activities
of Virbac SA.

What unique competitive advantages
does Virbac SA hold over its rivals?

What risks and challenges
does Virbac SA face in the near future?

Has there been any significant insider trading activity
in Virbac SA recently?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Virbac SA.

Provide P/S
for Virbac SA.

Provide P/E
for Virbac SA.

Provide P/OCF
for Virbac SA.

Provide P/FCFE
for Virbac SA.

Provide P/B
for Virbac SA.

Provide EV/S
for Virbac SA.

Provide EV/GP
for Virbac SA.

Provide EV/EBITDA
for Virbac SA.

Provide EV/EBIT
for Virbac SA.

Provide EV/OCF
for Virbac SA.

Provide EV/FCFF
for Virbac SA.

Provide EV/IC
for Virbac SA.

Show me price targets
for Virbac SA made by professional analysts.

What are the Revenue projections
for Virbac SA?

How accurate were the past Revenue estimates
for Virbac SA?

What are the Net Income projections
for Virbac SA?

How accurate were the past Net Income estimates
for Virbac SA?

What are the EPS projections
for Virbac SA?

How accurate were the past EPS estimates
for Virbac SA?

What are the EBIT projections
for Virbac SA?

How accurate were the past EBIT estimates
for Virbac SA?

Compare the revenue forecasts
for Virbac SA with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Virbac SA and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Virbac SA against its competitors.

Analyze the profit margins
(gross, operating, and net) of Virbac SA compared to its peers.

Compare the P/E ratios
of Virbac SA against its peers.

Discuss the investment returns and shareholder value creation
comparing Virbac SA with its peers.

Analyze the financial leverage
of Virbac SA compared to its main competitors.

Show all profitability ratios
for Virbac SA.

Provide ROE
for Virbac SA.

Provide ROA
for Virbac SA.

Provide ROIC
for Virbac SA.

Provide ROCE
for Virbac SA.

Provide Gross Margin
for Virbac SA.

Provide Operating Margin
for Virbac SA.

Provide Net Margin
for Virbac SA.

Provide FCF Margin
for Virbac SA.

Show all solvency ratios
for Virbac SA.

Provide D/E Ratio
for Virbac SA.

Provide D/A Ratio
for Virbac SA.

Provide Interest Coverage Ratio
for Virbac SA.

Provide Altman Z-Score Ratio
for Virbac SA.

Provide Quick Ratio
for Virbac SA.

Provide Current Ratio
for Virbac SA.

Provide Cash Ratio
for Virbac SA.

What is the historical Revenue growth
over the last 5 years for Virbac SA?

What is the historical Net Income growth
over the last 5 years for Virbac SA?

What is the current Free Cash Flow
of Virbac SA?

Discuss the annual earnings per share (EPS)
trend over the past five years for Virbac SA.

P/E
Price to Earnings

5.4

Current

20.5

Median

21.8

Industry

Lower than median

Lower than industry value

Price to Earnings (P/E) ratio is a valuation multiple that compares a company’s market capitalization to its net income. It indicates the dollar amount an investor can expect to invest in a company in order to receive $1 of that company’s earnings.

P/E

5.4

Market Cap

2.6B EUR

Net Income

480.1m EUR

All Countries

Forward Multiples

			Market Cap	P/E
FR		Virbac SA PAR:VIRP	2.6B EUR	5.4
JP	N	Nichi-Iko Pharmaceutical Co Ltd TSE:4541	776 550.9T JPY	-5 347 888.9
US		Eli Lilly and Co NYSE:LLY	755.8B USD	90.3
UK		Dechra Pharmaceuticals PLC LSE:DPH	440.4B GBP	-15 783.5
DK		Novo Nordisk A/S CSE:NOVO B	2.7T DKK	29
US		Johnson & Johnson NYSE:JNJ	351.1B USD	23.9
US		Merck & Co Inc NYSE:MRK	251.8B USD	20.7
CH		Roche Holding AG SIX:ROG	200.1B CHF	17.4
UK		AstraZeneca PLC LSE:AZN	161.8B GBP	31.6
CH		Novartis AG SIX:NOVN	171.5B CHF	10.8
US		Pfizer Inc NYSE:PFE	151.5B USD	35.6

				Earnings Growth	P/E to Growth
FR		Virbac SA PAR:VIRP	Average P/E: 29.4 5.4	55%	0.1
JP	N	Nichi-Iko Pharmaceutical Co Ltd TSE:4541	Negative Multiple: -5 347 888.9	N/A	N/A
US		Eli Lilly and Co NYSE:LLY	90.3	446%	0.2
UK		Dechra Pharmaceuticals PLC LSE:DPH	Negative Multiple: -15 783.5	N/A	N/A
DK		Novo Nordisk A/S CSE:NOVO B	29	86%	0.3
US		Johnson & Johnson NYSE:JNJ	23.9	-23%	N/A
US		Merck & Co Inc NYSE:MRK	20.7	7 300%	0
CH		Roche Holding AG SIX:ROG	17.4	54%	0.3
UK		AstraZeneca PLC LSE:AZN	31.6	177%	0.2
CH		Novartis AG SIX:NOVN	10.8	31%	0.3
US		Pfizer Inc NYSE:PFE	35.6	719%	0

P/E Forward Multiples

Forward P/E multiple is a version of the P/E ratio that uses forecasted net income for the P/E calculation. 1-Year, 2-Years, and 3-Years forwards use net income forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward

P/E

16.8

2-Years Forward

P/E

15.3

3-Years Forward

P/E

13.8

	Franklin Covey Co NYSE:FC	36.87 USD 1.57%
	Mohawk Industries Inc NYSE:MHK	120.01 USD -0.15%
	Ardmore Shipping Corp NYSE:ASC	12.12 USD 2.02%
	ASGN Inc NYSE:ASGN	83.46 USD -0.82%
	Skyworks Solutions Inc NASDAQ:SWKS	90.35 USD 0.18%
	Weatherford International PLC NASDAQ:WFRD	68.07 USD 1.95%

	Johnson & Johnson NYSE:JNJ	145.57 USD -0.19%
	Bank of America Corp NYSE:BAC	44.1953 USD -0.42%
	Mastercard Inc NYSE:MA	534.63 USD -0.2%
	Salesforce Inc NYSE:CRM	342.6 USD -0.53%
	Abbvie Inc NYSE:ABBV	180.3 USD 0.17%
	Home Depot Inc NYSE:HD	394.21 USD -0.44%

	Arista Networks Inc NYSE:ANET	114.49 USD -0.14%
	Visa Inc NYSE:V	318 USD -0.83%
	Texas Pacific Land Corp NYSE:TPL	1 161.2 USD 1.91%
	KLA Corp NASDAQ:KLAC	644.02 USD -1%
	Manhattan Associates Inc NASDAQ:MANH	280.81 USD -0.52%
	Pinduoduo Inc NASDAQ:PDD	99.9 USD 0.18%

	Salesforce Inc NYSE:CRM	342.6 USD -0.53%
	Accenture PLC NYSE:ACN	360.8 USD -0.23%
	ServiceNow Inc NYSE:NOW	1 108.323 USD 0.25%
	EOG Resources Inc NYSE:EOG	120.8 USD -0.02%
	Copart Inc NASDAQ:CPRT	58.84 USD -0.46%
	Applied Materials Inc NASDAQ:AMAT	167.18 USD -0.71%

Virbac SA
PAR:VIRP

P/E
Price to Earnings

P/E Forward Multiples

See Also

Company

Help

Tools

Stocks

Virbac SA PAR:VIRP

P/E Price to Earnings

P/E Forward Multiples

See Also

Company

Help

Tools

Stocks

Virbac SA
PAR:VIRP

P/E
Price to Earnings